Indoor Damp, Ventilation & Aspergillosis

What a Major UK Evidence Review Means for Patients and Professionals

This large UK Health and Safety Executive (HSE) review examined whether microorganisms inside buildings (homes, offices, workplaces) can harm health — and what actually helps reduce risk.

Although it does not focus on a single disease, its findings are highly relevant to people living with aspergillosis, asthma, bronchiectasis, and other chronic lung conditions, as well as the professionals who support them.

Link to paper

---

The short answer (for everyone)

Yes — indoor environments can significantly affect lung health.
And ventilation and moisture control are central to reducing risk, especially for people vulnerable to fungal exposure.

---

What the review confirms (in plain language)

1. Indoor fungi are common — and not harmless

High confidence evidence

Many buildings contain airborne and surface fungi, especially when dampness is present.
The fungi most often found indoors include:

• Aspergillus

• Penicillium

• Cladosporium

• Alternaria

For aspergillosis patients, this matters because:

• Aspergillus is not just an “outdoor mould”

• Ongoing exposure can worsen symptoms, trigger inflammation, or complicate recovery

• Even low levels may be problematic for sensitised or immunocompromised people

---

2. Dampness is a major driver of fungal exposure

High confidence

Damp buildings — whether due to leaks, condensation, or poor airflow — consistently show:

• Higher mould growth

• More fungal spores in the air

• Stronger links to respiratory symptoms

Important point for patients:

You do not need to see black mould for damp to be affecting your lungs.
Mould smell (“musty odour”) is one of the strongest warning signs.

---

3. Ventilation is the most important protective factor

High confidence

Ventilation:

• Dilutes fungal spores, bacteria, and viruses

• Reduces moisture build-up

• Lowers exposure for occupants

This applies to:

• Homes

• Flats

• Offices

• Other non-industrial indoor spaces

⚠️ The review highlights a key modern problem:
Energy-efficient, airtight buildings can unintentionally trap damp and fungi if ventilation is inadequate.

For aspergillosis patients, this means:

• A “warm” home is not always a “healthy” home

• Reduced airflow can increase fungal exposure even without visible mould

---

4. Indoor air also spreads infections

High confidence

Respiratory viruses (e.g. influenza, COVID-19) spread mainly through indoor air, especially when ventilation is poor.

This is relevant for aspergillosis patients because:

• Viral infections can destabilise lung disease

• Recovery may be slower

• Secondary infections are more likely

Ventilation therefore protects against both fungal and viral risks.

---

5. Surfaces matter too — but air matters more

Medium–high confidence

• Fungal material and microbes accumulate in dust, carpets, soft furnishings, and damp surfaces

• Toilets and bathrooms can generate contaminated aerosols

• Good hygiene helps, but cannot compensate for poor ventilation

For patients:

Cleaning alone will not solve a damp or ventilation problem.

---

What actually helps (evidence-based)

Strongest evidence

✔️ Adequate ventilation (natural or mechanical)
✔️ Fixing leaks and moisture sources
✔️ Removing mould-damaged materials
✔️ Preventing condensation on cold surfaces

Moderate evidence

✔️ HEPA air filtration (helpful but not a substitute for ventilation)
✔️ UV air disinfection (context-specific)
✔️ Touch-free fittings in shared buildings

⚠️ No single measure works on its own — combined approaches are needed.

---

Why this matters specifically for aspergillosis patients

This review strongly supports what many patients already experience:

• Symptoms may persist despite treatment if exposure continues

• Indoor environments can drive inflammation and relapse

• “Just take your medication” is not enough if housing conditions are harmful

Importantly, the review recognises that:

• Health effects vary by individual vulnerability

• Those with asthma, bronchiectasis, aspergillosis, or immune suppression are more sensitive

• There are no universally safe mould levels for everyone

---

What non-specialists should take from this

For GPs and clinicians

• Damp and poor ventilation are legitimate medical risk factors

• Persistent respiratory symptoms may be environment-driven

• Asking about housing conditions is clinically relevant

For housing, environmental health & social care

• Mould and damp are health hazards, not cosmetic defects

• Ventilation failures can directly affect chronic disease

• Energy efficiency must be balanced with respiratory health

For patients and carers

• You are not “overreacting” if your home affects your breathing

• Ventilation and moisture control are part of disease management

• Evidence supports advocating for safer living conditions

---

Bottom line

This major UK review confirms that indoor dampness and poor ventilation increase exposure to fungi — including Aspergillus — and worsen respiratory health.
For people living with aspergillosis, building conditions are not secondary issues: they are part of the disease environment.

Path: Start » Environment » Housing & Damp » Indoor Damp, Ventilation & Aspergillosis